Resultados da pesquisa - Heinz Weidenthaler

  • A mostrar 1 - 7 resultados de 7
Refinar resultados
  1. 1
    The changing epidemiology of human monkeypox – a potential threat? A systematic review

    The changing epidemiology of human monkeypox – a potential threat? A systematic review Por Eveline M. Bunge, Bernard Hoet, Liddy Chen, Florian Lienert, Heinz Weidenthaler, Lorraine R. Baer, Robert Steffen

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    The changing epidemiology of human monkeypox—A potential threat? A systematic review

    The changing epidemiology of human monkeypox—A potential threat? A systematic review Por Eveline M. Bunge, Bernard Hoet, Liddy Chen, Florian Lienert, Heinz Weidenthaler, Lorraine R. Baer, Robert Steffen

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine

    Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine Por Elke Jordan, Golam Kabir, Stephanie A. Schultz, Günter Silbernagl, Darja Schmidt, Victoria A. Jenkins, Heinz Weidenthaler, Daria Stroukova, Barbara K. Martin, Laurence De Moerlooze

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform

    The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform Por Ariane Volkmann, Anna‐Lise Williamson, Heinz Weidenthaler, Thomas P.H. Meyer, James S. Robertson, Jean‐Louis Excler, Richard Condit, Eric Evans, Emily Smith, Denny Kim, Robert T. Chen

    Publicado em 2020
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial

    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial Por Edgar T. Overton, Steven J. Lawrence, Eva Wagner, Katrin Nopora, Siegfried Rösch, Philip Young, Darja Schmidt, Christian Kreusel, Sonja De Carli, Thomas Meyer, Heinz Weidenthaler, Nathaly Samy, Paul Chaplin

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

    One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines Por Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Jacqueline D Powell, Thomas P.H. Meyer, Günter Silbernagl, Richard Nichols, Heinz Weidenthaler, Laurence De Moerlooze, Liddy Chen, Paul Chaplin

    Publicado em 2022
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox

    Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox Por Phillip R. Pittman, Matthew W. Hahn, HeeChoon S. Lee, Craig Koca, Nathaly Samy, Darja Schmidt, Joachim Hornung, Heinz Weidenthaler, Christopher R. Heery, Thomas P.H. Meyer, Günter Silbernagl, Jane Maclennan, Paul Chaplin

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: